Quantitative Magnetic Resonance Imaging of the Liver and Heart In Iron Overload

Systemic iron overload (IO) is considered a principal determinant in the clinical outcome of different forms of IO and in allogeneic hematopoietic stem cell transplantation (alloSCT). However, indirect markers for iron do not provide exact quantification of iron burden, and the evidence of iron-induced adverse effects in hematological diseases has not been established. Hepatic iron concentration (HIC) has been found to represent systemic IO, which can be quantified safely with magnetic resonance imaging (MRI), based on enhanced transverse relaxation. The iron measurement methods by MRI are evolving. The aims of this study were to implement and optimise the methodology of non-invasive iron measurement with MRI to assess the degree and the role of IO in the patients. An MRI-based HIC method (M-HIC) and a transverse relaxation rate (R2*) from M-HIC images were validated. Thereafter, a transverse relaxation rate (R2) from spin-echo imaging was calibrated for IO assessment. Two analysis methods, visual grading and rSI, for a rapid IO grading from in-phase and out-of-phase images were introduced. Additionally, clinical iron indicators were evaluated. The degree of hepatic and cardiac iron in our study patients and IO as a prognostic factor in patients undergoing alloSCT were explored. In vivo and in vitro validations indicated that M-HIC and R2* are both accurate in the quantification of liver iron. R2 was a reliable method for HIC quantification and covered a wider HIC range than M-HIC and R2*. The grading of IO was able to be performed rapidly with the visual grading and rSI methods. Transfusion load was more accurate than plasma ferritin in predicting transfusional IO. In patients with hematological disorders, the prevalence of hepatic IO was frequent, opposite to cardiac IO. Patients with myelodysplastic syndrome were found to be the most susceptible to IO. Pre-transplant IO predicted severe infections during the early post-transplant period, in contrast to the reduced risk of graft-versus-host disease. Iron-induced, poor transplantation results are most likely to be mediated by severe infections.

Suomenkielisen maantiedon kouluopetuksen alkuvaiheet

Allan Tiitta

Keijujen uusi elämä lehtien palstoilla

Kirjallisuusarvostelu

Pharmacokinetics of Oxycodone and Paracetamol in the Elderly. Clinical Pharmacokinetic Study on Orthopaedic Surgical Patients and Healthy Volunteers

The proportion of elderly people over 65 years of age in Finland is expected to grow to over 25% by the 2025. It has been estimated that elderly people today consume nearly 40% of all drugs. Age brings about number of physiological changes that may affect the disposition, metabolism and excretion of drugs. The function of heart, lungs, liver and kidneys decreases even in healthy people, as they get older. The proportion of total body water decreases and the relative fat percentage increases. Also several other factors such as concurrent diseases, concomitant medication and nutritional factors have an effect on drug therapy in elderly. Age increases the risk of adverse drug reactions, which most often are dose-dependent. Despite all this there are not enough studies involving the elderly people and the elderly are most often excluded from clinical trials. Oxycodone is a strong opioid analgesic, which is used to treat moderate or severe pain. Paracetamol is a widely used nonopioid analgesic, which has become popular in the treatment of pain in many patient groups. In this series of studies the pharmacokinetics of oral and intravenous oxicodone as well as intravenous paracetamol in the elderly and young adult patients were investigated. Also a study investigating the interaction of oral antibiotic clarityhromycin, a known cytochrome P450 (CYP) 3A4 inhibitor, with oxycodone pharmacokinetics and pharmacodynamics in elderly and young healthy volunteers was carried out. The pharmacokinetics of oxycodone showed a clear age depency. Patients over 70 years had 50-80% higher mean exposure to oral oxycodone and a twofold greater plasma concentration than young adults 12 h after ingestion of the drug. Elderly patients had 40-80% greater exposure to intravenous oxycodone and patients over 80 years had over twofold greater plasma concentrations 8 h post dose than the young adults. The elderly patients had also greater exposure to intra venous paracetamol compared to young adults. Clarithromycin increased the exposure to oral oxycodone in both young and elderly volunteers. The elderly had marked interindividual variation in the pharmacokinetics and pharmacodynamics when clarithromycin was given concomitantly with oxycodone. Because the pharmacokinetics of oxycodone and intravenous paracetamol depend on the age of the subject, it is important to titrate the analgesic dose individually in the elderly.

Kunnianhimoinen tutkimus sarjakuvasta

Kirjallisuusarvostelu

Biomarkers, medical treatment and fetal intrapartum surveillance in intrahepatic cholestasis of pregnancy

Intrahepatic cholestasis of pregnancy (ICP) is a pregnancy-specific disorder characterized by maternal pruritus and elevated liver enzymes. It usually begins in the third trimester of pregnancy and resolves spontaneously after delivery. ICP is considered benign for the pregnant woman, but it is associated with an increased risk for unexplained term stillbirth and preterm delivery. There are no specific laboratory markers to diagnose ICP. The diagnosis is currently based on the presence of maternal pruritus and elevated values of alanine aminotransaminases (ALT) and serum bile acids (BA). Recently, ursodeoxycholic acid (UDCA) has been used for treatment. Mechanisms leading to intrauterine fetal death (IUFD) may be multifactorial and are unknown at present. For this thesis, 415 pregnant women with ICP were studied. The aim was to evaluate the value of the liver enzyme glutathione S-transferase alpha (GSTA) as a specific marker of ICP and to assess the effect of maternal UDCA therapy on maternal laboratory values and fetal outcome. The specific markers predisposing the fetus to heart arrhythmia were studied by comparing waveform analysis of fetal electrocardiograms (FECG) during labor in pregnancies complicated by ICP with controls. The levels of maternal GSTA were high and the values correlated with the value of ALT in patients with ICP. UDCA therapy reduced the values of the liver enzymes and alleviated maternal pruritus, but it did not influence maternal hormonal values. Although the newborns experienced an uneventful perinatal outcome, severe ICP was still associated with preterm birth and admission to the neonatal intensive care unit (NICU). There were no significant differences in intrapartum FECG findings between fetuses born to ICP women and controls.

Sydämen eteisvärinän tunnistaminen matkapuhelimen kiihtyvyysanturilla

Yli 140 miljoonaa ihmistä kärsii kroonisesta eteisvärinästä. Monilla ihmisillä on eteisvärinää, vaikkeivat siitä itse tiedä. Hoito on yksinkertainen, mutta hoidon piiriin eivät päädy kaikki yksinkertaisten seulontamenettelyjen tuloksena. Elektrokardiogrammi (EKG) sydämen toimintojen tunnistusmenetelmänä on tällä hetkellä yleisin vaihtoehto eteisvärinän seulontaan. EKG-laitteet ovat arvokkaita ja haasteellisia yksittäisen käyttäjän arkielämän kannalta. Vaihtoehtoinen sydämen monitorointimenetelmä on ballistokardiografinen (BKG) mittaus. EKG:n ja BKG:n ominaisia piirteitä käydään lävitse ja vertaillaan vahvuuksia sekä heikkouksia näiden kahden mittausmenetelmän välillä. BKG:ta on tutkittu jo pitkään, mutta mittaukseen soveltuvia tähän käyttökohteeseen varsinaisesti suunniteltuja laitteita ei ole paljoakaan tuotteistettu markkinoille asti. Työssä tutkitaan matkapuhelimen kiihtyvyysanturin soveltuvuutta BKG-mittauksen suorittamiseen. Tällä menetelmällä on mahdollista tuoda helposti sydänmonitori lähelle ihmisiä ja jokainen voi omalla matkapuhelimellaan tarkkailla sydämensä toimintaa. Diplomityössä selvitetään erilaisten markkinoilla olevien mobiililaitteiden soveltuvuutta kiihtyvyysanturitutkimukseen. Useampaa mallia koskevan selvitystyön tuloksena valitaan parhaiten toimiva vaihtoehto, jolla jatketaan tutkimusta suunnittelemalla mittausprosessi. Ensimmäisen vaiheen mittauksissa valitaan 20 perustervettä koehenkilöä tutkimukseen. Tutkimuksen tuloksena saadaan tutkimushypoteesin mukainen tulos ja sydämen lyönnit saadaan tunnistettua kaikilla koehenkilöillä. Ensimmäisen vaiheen aikana suoritetaan myös liikehäiriötutkimusta. Tässä suoritetaan yksinkertaiset käden, jalan ja pään liikkeiden vaikutuksen arvioinnit kiihtyvyysanturisignaaliin. Lisäksi selvitetään, miten puhuminen mittauksen aikana välittyy tutkimuslaitteeseen ja suoritetaan arvio siitä, miten tämä voidaan ottaa huomioon. Ensimmäisen vaiheen havaintojen perusteella jatkokehitetään mittausprosessia ja pyritään optimoimaan tätä, jotta laajempi otosjoukko on mahdollista saavuttaa mahdollisimman vähän aikaresursseja kuluttaen. Työssä valmistellaan laajemman, 1000 koehenkilöä sisältävän, toisen tutkimusvaiheen suoritusta. Diplomityön osana valmistellaan Varsinais-Suomen Sairaanhoitopiirin eettiselle toimikunnalle lausuntohakemus tutkimukselle. Hakemuksessa käsitellään laajasti tutkimuksen suorittamista eri osa-alueilla. Toisen vaiheen tuloksen noudattaessa tutkimushypoteesia, voidaan todeta matkapuhelimen kiihtyvyysanturin olevan soveluva menetelmä sydämen toiminnan tutkimiseen.